Clearside Biomedical Announces Positive 6-Month Results
- Suprachoroidal CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months in Treatment-Experienced Anti-VEGF Sub-Responders -...
United States University Of Arizona Markr Barakat Thomasa Ciulla George Lasezkay Retinal Research Institute
Source: globenewswire.com